» Articles » PMID: 4150831

Interaction of Delta9-tetrahydrocannabinol and Cannabidiol on Intestinal Motility in Mice

Overview
Specialties Pharmacology
Pharmacy
Date 1974 Feb 1
PMID 4150831
Citations 13
Authors
Affiliations
Soon will be listed here.
Citing Articles

Effects of Cannabinoids on Intestinal Motility, Barrier Permeability, and Therapeutic Potential in Gastrointestinal Diseases.

Crowley K, Kiraga L, Miszczuk E, Skiba S, Banach J, Latek U Int J Mol Sci. 2024; 25(12).

PMID: 38928387 PMC: 11203611. DOI: 10.3390/ijms25126682.


Cannabidiol and Intestinal Motility: a Systematic Review.

Story G, Briere C, McClements D, Sela D Curr Dev Nutr. 2023; 7(10):101972.

PMID: 37786751 PMC: 10541995. DOI: 10.1016/j.cdnut.2023.101972.


The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.

Jamontt J, Molleman A, Pertwee R, Parsons M Br J Pharmacol. 2010; 160(3):712-23.

PMID: 20590574 PMC: 2931570. DOI: 10.1111/j.1476-5381.2010.00791.x.


Interactions between THC and cannabidiol in mouse models of cannabinoid activity.

Varvel S, Wiley J, Yang R, Bridgen D, Long K, Lichtman A Psychopharmacology (Berl). 2006; 186(2):226-34.

PMID: 16572263 DOI: 10.1007/s00213-006-0356-9.


Cannabinoids and the gastrointestinal tract.

Pertwee R Gut. 2001; 48(6):859-67.

PMID: 11358910 PMC: 1728337. DOI: 10.1136/gut.48.6.859.